REGOMUNE

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Ouvert à Saint-Cloud depuis le : 25/10/2021
Public cible : Adult
Phase : Phase I/II

Description de l'essai

Assessment of the efficacy and safety of Regorafenib and Avelumab in patients with advanced or metastatic solid tumors (ten cohorts), once the Recommanded Phase II Dose (RP2D) has been determined (phase I trial).

Url of the trial

Investigateur principal

SEGOLENE HESCOT

Médecin

Contacter